Efficacy of nicorandil in acute coronary syndrome

Phase 2

• Conditions: Acute coronary syndrome.; Ischaemic heart disease; 120_125

• Registration Number: IRCT201202189067N1
• Lead Sponsor: Vice chancellor for research, Kermanshah University of Medical Siences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 252

Inclusion Criteria

Inclusion criterion:Non ST elevation acute coronary syndrome.
Exclusion criteria: myocardial infarction with ST levation and Left Bundle Branch Block

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response treatment. Timepoint: During hospitalization daily. Method of measurement: Physician visit.

Secondary Outcome Measures

Name	Time	Method
Clinical side effect. Timepoint: During hospitalization daily. Method of measurement: Physician visit.